Dopamine Reduction in the Substantia Nigra of Parkinson's Disease Patients Confirmed by In Vivo Magnetic Resonance Spectroscopic Imaging

Open Access

Peer-reviewed

Research Article

Adriane Gröger ,

* E-mail: adriane.groeger@med.uni-tuebingen.de

Affiliation Department of Diagnostic and Interventional Neuroradiology, Magnetic Resonance Research Group, University Hospital Tübingen, Tübingen, Germany
⨯
Rupert Kolb,

Affiliation Department of Diagnostic and Interventional Neuroradiology, Magnetic Resonance Research Group, University Hospital Tübingen, Tübingen, Germany
⨯
Rita Schäfer,

Affiliation Department of Diagnostic and Interventional Neuroradiology, Magnetic Resonance Research Group, University Hospital Tübingen, Tübingen, Germany
⨯
Uwe Klose

Affiliation Department of Diagnostic and Interventional Neuroradiology, Magnetic Resonance Research Group, University Hospital Tübingen, Tübingen, Germany
⨯

Reader Comments (0)

Metabolites
Is the Subject Area "Metabolites" applicable to this article?

Thanks for your feedback.
Dopamine
Is the Subject Area "Dopamine" applicable to this article?

Thanks for your feedback.
Parkinson disease
Is the Subject Area "Parkinson disease" applicable to this article?

Thanks for your feedback.
Magnetic resonance imaging
Is the Subject Area "Magnetic resonance imaging" applicable to this article?

Thanks for your feedback.
Neurons
Is the Subject Area "Neurons" applicable to this article?

Thanks for your feedback.
Substantia nigra
Is the Subject Area "Substantia nigra" applicable to this article?

Thanks for your feedback.
Magnetic resonance
Is the Subject Area "Magnetic resonance" applicable to this article?

Thanks for your feedback.
Magnetic resonance spectroscopy
Is the Subject Area "Magnetic resonance spectroscopy" applicable to this article?

Thanks for your feedback.